Company Performance - Doximity (DOCS) closed at $61.55, with a +2.24% increase from the previous day, outperforming the S&P 500's gain of 0.14% [1] - Prior to the latest trading session, Doximity shares had gained 7.65%, contrasting with the Medical sector's loss of 1.34% and the S&P 500's gain of 3.97% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.31, reflecting a 10.71% increase year-over-year [2] - Revenue is anticipated to be $139.67 million, indicating a 10.26% rise compared to the same quarter last year [2] - For the annual period, earnings are projected at $1.46 per share and revenue at $625.72 million, representing increases of +2.82% and +9.7% respectively from the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for Doximity suggest a favorable outlook on the company's business health and profitability [4] - The Zacks Rank system indicates that changes in estimates are correlated with stock price performance, with Doximity currently holding a Zacks Rank of 3 (Hold) [5][6] Valuation Metrics - Doximity is trading at a Forward P/E ratio of 41.26, which is a premium compared to the industry average of 28.13 [7] - The company has a PEG ratio of 4.48, while the Medical Info Systems industry has an average PEG ratio of 2.64 [8] Industry Context - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 85, placing it in the top 35% of over 250 industries [9] - Research indicates that industries in the top 50% outperform those in the bottom half by a factor of 2 to 1 [9]
Doximity (DOCS) Rises Higher Than Market: Key Facts